公司資料
Avidity Biosciences 股價、新聞與催化劑
- 股票代碼:
- RNA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.14 USD (-1.69%)
收盤價
最後更新: 2026年10月1日
210M USD
市值
股價為何變動
截至 2026年10月1日，RNA 下跌 1.69%，收於 $8.14。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Avidity sits in advanced biotechnology.
商業模式特徵
The company depends on platform validation, clinical data, and the promise of targeted RNA delivery to hard-to-reach tissues.
生技產業定位
Avidity is one of the most interesting RNA-delivery names because platform success could unlock multiple disease areas.
未來催化劑
- Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform. The market will care about whether the platform keeps producing convincing in-human signals.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。